Beta Glucan Based Products Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-01-28　·　133 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 710 Mn
2033 年預估規模: USD 1,250 Mn
年複合成長率 CAGR: 9.8%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Food & Beverage出版日期 2026-01-28頁數 133報告編號 CMI2597

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Beta Glucan Based Products Market, By Source (Cereals, Yeast, Mushroom, and Others), By Grade (Pharma, Medical, Food, Cosmetics, Enhanced Oil Recovery (EOR), and Animal Feed), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

報告摘要

Beta glucan is an important component of dietary fiber, which can be extracted from oat, barley, bacteria, and yeast. It possesses several physiological effects, including lowering plasma cholesterol level, control of postprandial glucose level, and immune modulation effects. Apart from the food industry, beta glucan is increasingly being used in the pharmaceutical, medical, cosmetic, and industrial applications, and end product manufacturing. Βeta glucans can act as an immune system modulator and also has the ability to reduce blood glucose, and it may be used in the treatment of diabetes mellitus. Beta glucans can protect the body from heart attack by lowering cholesterol levels and it also acts as an anti-tumor agent. Beta glucans are used in medical field to treat various diseases including hyper cholesterolemia, diabetes, cancer, and HIV/AIDS. Market Dynamics Increasing applications of beta glucan as potential active ingredient in various food, medical, pharmaceutical, animal feed, and industrial applications is expected to increase demand for beta glucan and this is expected to aid in growth of the market in the near future. Moreover, health benefits of beta glucan along with changing consumer preferences towards use of nutritious food and dietary supplements among global population is expected to propel the market growth. Furthermore, key players in the market are focusing on gaining significant market share by adopting various strategies and this is expected to aid in the market growth. For instance, in April 2017, Kemin Industries acquired a beta-glucan manufacturing technology from Algal Scientific, a company headquartered in Plymouth, U.S. In October 2014, NutraQ announced that it entered into a distribution partnership with American International Chemical LLC (AIC) to exclusively distribute NBG range of beta-glucans in in the U.S., Canada, and Mexico. Key features of the study • This report provides in-depth analysis of beta glucan based products market and provides market size (USD Mn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026 – 2033), considering 2025 as the base year • It elucidates potential revenue opportunity across different segments and explains an attractive investment proposition matrix for this market • This study also provides key insights into market drivers, restraints, opportunities, scoliosis management product approval & launch, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global beta glucan based products market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans • Key companies covered as part of this study include Jkosmmune, Lesaffre Group, Merck KGaA, Garuda International, Inc., Ohly GmBH, Koninklijke DSM N.V., Kerry Group PLC, STR Biotech Co. Ltd., Macrocare Tech Co., Ltd., Amarte USA, LLC, Ceapro Inc., Biotec Pharmacon ASA, Quegen Biotech Co., Ltd., Kemin Industries, Inc., NutraQ AS, Lantmännen, Carbon Medical Technologies, Inc., Givaudan SA, Danaher Corporation, Super Beta Glucan Inc., and AIPPO • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, manufacturing up-gradation, market expansion, and marketing tactics • The global beta glucan based products market report caters to various stakeholders in this industry including investors, suppliers, beta glucan based product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the beta glucan based products market Market Segmentation • Source Insights (Revenue, USD Mn, 2026 - 2033) o Cereals o Yeast o Mushroom o Others • Grade Insights (Revenue, USD Mn, 2026 - 2033) o Pharma o Medical o Food o Cosmetics o Enhanced Oil Recovery o Animal Feed • Regional Insights (Revenue, USD Mn, 2026 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC  Israel  Rest of Middle East o Africa  North Africa  Central Africa  South Africa • Key Players Insights o Jkosmmune o Lesaffre Group o Garuda International, Inc. o Ohly GmbH o Koninklijke DSM N.V. o Kerry Group PLC o STR Biotech Co. Ltd. o Macrocare Tech Co., Ltd. o Amarte USA, LLC o Ceapro Inc. o Biotec Pharmacon ASA o Quegen Biotech Co., Ltd. o Kemin Industries, Inc. o NutraQ AS o Lantmännen o Carbon Medical Technologies, Inc. o Givaudan SA o Danaher Corporation o Super Beta Glucan Inc. o AIPPO

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Overview o Report Description  Market Definition and Scope o Executive Summary  Global Beta Glucan Based Products Market, By Source  Global Beta Glucan Based Products Market, By Grade  Global Beta Glucan Based Products Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Key Developments o Industry Trend 4. Global Beta Glucan Based Products Market, By Source, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Cereals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Yeast  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Mushroom  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) 5. Global Beta Glucan Based Products Market, By Grade, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Pharma  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Medical  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Food  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Cosmetics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Enhanced Oil Recovery (EOR)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Animal Feed  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) 6. Global Beta Glucan Based Products Market, By Region, 2026 - 2033, Value (USD Mn) o Introduction  Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)  Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Mn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Source, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Grade, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Source, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Grade, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Source, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Grade, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Source, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Grade, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Source, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Grade, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Source, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Grade, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn) o South Africa o North Africa o Central Africa 7. Competitive Landscape o Jkosmmune  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Lesaffre Group  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Garuda International, Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Ohly GmBH  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Koninklijke DSM N.V.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Kerry Group PLC  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o STR Biotech Co. Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Macrocare Tech Co., Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Amarte USA, LLC  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Ceapro Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Biotec Pharmacon ASA  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Quegen Biotech Co., Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Kemin Industries, Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o NutraQ AS  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Lantmännen  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Carbon Medical Technologies, Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Givaudan SA  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Danaher Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Super Beta Glucan Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o AIPPO  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 8. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 9. References and Research Methodology o References o Research Methodology o About us

提及公司

JkosmmuneLesaffre GroupGaruda International, Inc.Ohly GmbHKoninklijke DSM N.V.Kerry Group PLCSTR Biotech Co. Ltd.Macrocare Tech Co., Ltd.Amarte USA, LLCCeapro Inc.Biotec Pharmacon ASAQuegen Biotech Co., Ltd.Kemin Industries, Inc.NutraQ ASLantmännenCarbon Medical Technologies, Inc.Givaudan SADanaher CorporationSuper Beta Glucan Inc.AIPPO

同分類最新報告（食品與飲料）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們